Evidence map›Paper›PMID 37676005›Full record

ArticleMicrobiology spectrum2023

Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.

Shima Shahbaz, Najmeh Bozorgmehr, Julia Lu, Mohammed Osman, Wendy Sligl, D Lorne Tyrrell, Shokrollah Elahi

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Host Responses to SARS-CoV-2 with an Emphasis on Cytokines.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Polyfunctional CD8Molecular oncology · 2025
    Article
  15. Article
  16. Dichotomous effects of Galectin-9 in disease modulation in murine models of inflammatory bowel disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shima ShahbazDivision of Foundational Sciences, School of Dentistry, University of Alberta , Edmonton, Alberta, Canada.
Najmeh BozorgmehrDivision of Foundational Sciences, School of Dentistry, University of Alberta , Edmonton, Alberta, Canada.
Julia LuDivision of Foundational Sciences, School of Dentistry, University of Alberta , Edmonton, Alberta, Canada.
Mohammed OsmanDivision of Rheumatology, Department of Medicine, University of Alberta , Edmonton, Alberta, Canada.
Wendy SliglDepartment of Critical Care Medicine, University of Alberta , Edmonton, Alberta, Canada.
D Lorne TyrrellDepartment of Medical Microbiology and Immunology, University of Alberta , Edmonton, Alberta, Canada.
Shokrollah ElahiDivision of Foundational Sciences, School of Dentistry, University of Alberta , Edmonton, Alberta, Canada.ORCID 0000-0002-7215-2009
University of Alberta · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) 453061
6 · The paper itself

Abstract

importanceThere is a need to better understand how different SARS-CoV-2 variants influence the immune system and disease dynamics to facilitate the development of better vaccines and therapies. We compared immune responses in 140 SARS-CoV-2-infected individuals with the Wuhan strain, the Delta variant, or the Omicron variant. All these patients were admitted to the intensive care unit and were SARS-CoV-2 vaccination naïve. We found that SARS-CoV-2 variants differentially affect the host immune response. This was done by measuring soluble biomarkers in their plasma and examining different immune cells. Overall, we found that the magnitude of cytokine storm in individuals infected with the Wuhan strain or the Delta variant was greater than in those infected with the Omicron variant. In light of enhanced cytokine release syndrome in individuals infected with the Wuhan strain or the Delta variant, we believe that a milder innate immune response might be beneficial and protective in those infected with the Omicron variant.

Indexed as

co-inhibitory receptorsCOVID-19cytokinesgalectinssoluble immune checkpoints

Identifiers

PMID37676005
PMCPMC10581158
OpenAlexW4386496927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.